FROM NEWSWEEK Should Birth Control On Campus Be Free? Experts are discussing whether the birth-control pill should be considered preventive care under Obama’s health plan. Every month George Washington University freshman Jessi Payton walks to the pharmacy on campus and pays $15 for her birth-control prescription. Her mother’s insurance covers the bulk of the cost, and the rest comes from the money she saved waiting tables last summer. Since she doesn’t have a steady income, Payton is grateful for her mom’s assistance. “I know so many people who need to go on the pill, and they can’t because it costs too much money or their parents won’t pay for it with their insurance,” she says. “It’s scary because that doesn’t mean they aren’t having sex.” While college health centers have been handing out complimentary condoms to students for years, birth-control pills have always been held under lock and key (unless, you have a prescription and a way to pay). Under President Obama’s new health-care plan, however, that could all change. A panel of experts got together last month to begin discussing which kind of preventive care for women should be covered for free. Sen. Barbara Mikulski, who wrote the women’s health amendment to the plan, has said the aim was always to include family planning. But whether the birth-control pill falls under that definition and whether it should be deemed preventive medicine—and hence, free—has sparked a debate from college campuses to Capitol Hill READ MORE Add Comment "The science of improving lives"Sino-implant (II) According to United Nations estimates, about 200 million women worldwide have an unmet need for safe and effective contraception--that is, they neither want to get pregnant nor do they use a modern form of family planning. As a result, each year 70 to 80 million women face unwanted pregnancies. Contraceptive implants, which were introduced more than 25 years ago, are one of the most effective family planning methods developed to date. Even though they have potential to reduce the number of unwanted pregnancies significantly, they are underutilized, primarily because of their high cost. Few programs and clinics are able to offer the method and stockouts are frequent. To address these problems, FHI is facilitating the introduction of Sino-implant (II)--a long-acting, safe, and affordable contraceptive implant. Sino-implant (II) cost about 60 percent less than implants on the market in 2009, according to the Reproductive Health Supplies Coalition database. As a result, it can be offered to women on a much broader scale than the other implants and reduce the high unmet need for contraception. Sino-implant (II) is a subdermal contraceptive implant manufactured in China by Shanghai Dahua Pharmaceutical Co., Ltd. It has an annual pregnancy rate below 1 percent. The product is composed of two thin, flexible, silicone rods, each containing 75 mg levonorgestrel (a synthetic form of the hormone progesterone). These are inserted under the skin of a woman's arm or thigh by a trained health care provider. Sino-implant (II) is currently labeled for four years of use. From Popular Science Birth Control Pills Shown to Alter Structure of Women's Brains You aren't yourself anymore. It's a familiar complaint heard by women who have recently gone on birth control pills. Now studies are providing evidence for what many of those women, and the men who love them, have long known intuitively: the pill can alter the female brain, making a woman act like a different person. The pill turned 50 this year, and it has gone through many iterations since the Food and Drug Administration gave the pharmaceutical company G.D. Searle a green light to market the first oral contraceptive on June 23, 1960. Drug companies continually roll out contraceptives containing lower doses of hormones and entailing fewer side effects. But women who have gone on hormones can point to the effects that have stubbornly endured: moodiness, depression, decreased libido. (This last one makes some birth control pills perversely effective. Not only do they protect you from pregnancy if you do have sex, they also zap your desire to have sex in the first place -- and turn you into an unstable mess, which may in turn zap your partner's interest in sex.) But believe it or not, we still know very little about the consequences of taking daily hormones on a woman's brain. That is changing, say Craig H. Kinsley and Elizabeth A. Meyer in Scientific American. They point to a recent study in the journal Brain Research comparing the brains of women on birth control pills with brains of other women and men. When the study's authors examined high-resolution images of participants' brains, they found the women on hormones showed more matter in some areas of the brain, including the prefrontal cortex, which is associated with cognitive activities like decision-making. The Brain Research study prompted breathless news reports suggesting that the pill makes you smarter. But Kinsley and Meyer point out that the brain works like a "neural beehive," and disturbing one part of the hive could impact the other. The fact that one brain region becomes larger than the next does not mean a woman on hormones is more intelligent or effective. It is also possible that her brain is going haywire. (Kinsley and Meyer actually use the word "catawampus.") READ MORE And now...the "week-after" pill? Saturday August 14, 2010 :The Food and Drug Administration approved a controversial new form of emergency contraception Friday that can prevent a pregnancy as many as five days after sex. The decision to allow the sale of the pill, which will be marketed under the brand name "ella," was welcomed by family-planning proponents as a crucial new option to prevent unwanted pregnancies. But critics condemned the decision, arguing that it was misleading to approve ella as a contraceptive because the drug could also be used to induce an abortion. Ella can cut the chances of becoming pregnant by about two-thirds for at least 120 hours after a contraceptive failure or unprotected sex, studies have shown. The only other emergency contraceptive on the market, the so-called morning-after pill sold as Plan B, is significantly less effective, becomes less effectual with each passing day and will not work after 72 hours. Supporters and opponents both said the decision marked the clearest evidence of a shift in the influence of political ideology at the FDA. The last time the FDA considered an emergency contraceptive -- making Plan B available without a prescription -- the decision was mired in controversy amid similar concerns voiced by antiabortion activists. After repeated delays, Plan B was approved for sale to women 17 and older without a prescription. Ella, which was approved in Europe last year and is available in at least 22 countries, was unanimously endorsed by an FDA advisory committee less than two months ago. Women will need a prescription but could keep a supply at home. Read more: http://blog.beliefnet.com/deaconsbench/2010/08/and-nowthe-week-after-pill.html#ixzz0xOEelzhd By jamming the biochemical machinery of sperm, an Israeli professor has created a new pill that could finally place the responsibility of birth control with men. Biochemist Prof. Haim Breitbart hopes a new birth control pill for men could be on the market in as little as five years.The female birth control pill, commonly referred to as 'The Pill,' is not 100 percent effective, and some women's bodies don't react well to the extra hormones. Now, finally, a new birth control option for men is in the works, which would allow partners to share the responsibility, and let guys be in control of whether or not there will be any surprises in the procreation department. Prof. Haim Breitbart of Israel's Bar-Ilan University authored a breakthrough paper in 2006 describing how sperm survive in the uterus. Now the biochemist is taking those findings and using them against sperm. He's developed a number of novel compounds that have no affect on male sex drive, but succeed in impairing the reproductive ability of the sperm. If all goes according to his plan, a new male birth control pill could be on the market within the next five years, he tells ISRAEL21c. So far, the new pill dubbed the Bright Pill (a play on Brietbart's name) has been tested on animal models in a pre-clinical setting, and has been found to work wonderfully on mice. "What we found is that by treating the mice with our molecule we can get sterility for a long period of time; in the lower dose, about one month, and in the higher dose we found three months of sterility. "Later on the male mouse can become fertile. It's reversible," he promises. Provided in pill form, but also tested as an injection, the male birth control solution was administered in two treatments over three days: One day on, one day off, one day on. In the larger dose group, it took about a week until the effects manifested themselves, but most importantly, the treatment does not appear to in any way affect the sex drive or the sexual behavior of the mice who received it. "The mice behaved nicely, they ate and had sex" "The mice behaved nicely," Breitbart reports, "they ate and had sex; they were laughing, and everything, so all I can say is that we couldn't see any behavioral side-effects - all their sex behavior was retained, which is a very important consideration for human men. A man who takes this pill could also be sexually active later on and have children." Rather than undergo an irreversible vasectomy, a man could sterilize himself for short periods, suggests Breitbart - probably one to three months depending on the dose. And, unlike the female pill, the male pill wouldn't have to be taken every day. Scientifically speaking, the effects of the male pill would be highly specific, meaning men would likely experience fewer side effects than do women who go on the pill. Careful not to reveal any of his trade secrets, Breitbart will divulge that the male pill is based on techniques in bioinformatics and microbiology and shows no sign of attacking any cells other than sperm cells. READ MORE | All News
ArchivesFebruary 2011 CategoriesAll |





RSS Feed